Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials
Finding strategies for preventing preeclampsia is a top priority in the field of preeclampsia research. In this study, the authors reviewed all research papers available up until September 2021 that reported the effect of a preeclampsia prevention strategy and compared the strategies and how well they worked. (What is known as a meta-analysis.)
A total of 130 trials and 112,916 participants were included in this study, spanning 13 strategies for preeclampsia prevention. The strategies studied were lifestyle strategies (exercise, rest), medications (aspirin, metformin, pravastatin, low molecular weight heparin), and supplements (fish oil, folic acid, magnesium, selenium, vitamin C and E, vitamin D, and calcium). The analysis found that aspirin, exercise, calcium supplementation, vitamin D supplementation and low-molecular-weight heparin were all successful strategies for reducing risk for preeclampsia.
When comparing these successful strategies to one another, none were superior to the other for preeclampsia prevention. However, exercise was superior compared to aspirin and calcium supplementation, when considering reducing risk for all pregnancy-induced hypertension diagnoses.
Take Home Message: The sheer number of articles available to analyze in this study is promising evidence for progress in the field of preeclampsia prevention. This article shows there are several worthwhile strategies for patients to discuss with their health care provider to possibly implement to reduce their risk for preeclampsia. A lot more research is still needed to improve preeclampsia prevention.
Link: https://www.ajog.org/article/S0002-9378(22)00819-5/fulltext
Citation: Liu, Yuan-hui et al. Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials American Journal of Obstetrics & Gynecology, Volume 228, Issue 5, 535 - 546 (2023). https://doi.org/10.1016/j.ajog.2022.10.014
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Placental dysfunction can result in conditions such as preeclampsia, which have traditionally been managed with close monitoring and appropriately timed delivery. There is currently no cure for preecl...
Gestational hypertension continues to be a growing public health concern contributing to maternal morbidity, mortality, and long-term health complications in the U.S. While changes in vision—suc...
Background Low-dose aspirin (81 mg) is a treatment known to help lower the risk of preeclampsia. However, not everyone who is at higher risk is told to take it. This study looks at whether a screening...
Women who experienced Preeclampsia have a higher lifetime risk of developing cardiovascular disease (CVD) than women who did not suffer from this pregnancy complication. Researchers wanted to know if...
Preeclampsia Foundation and Preeclampsia Foundation Canada announced that applications are now being accepted for the 2026 Vision Grant research funding program. Three of the four grants focus on heal...
